SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-067217
Filing Date
2018-11-09
Accepted
2018-11-09 09:49:41
Documents
78
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19039_110q.htm 10-Q 1288345
2 EX-2.1 a18-19039_1ex2d1.htm EX-2.1 556284
3 EX-31.1 a18-19039_1ex31d1.htm EX-31.1 12401
4 EX-31.2 a18-19039_1ex31d2.htm EX-31.2 12415
5 EX-32.1 a18-19039_1ex32d1.htm EX-32.1 6607
6 EX-32.2 a18-19039_1ex32d2.htm EX-32.2 6628
  Complete submission text file 0001104659-18-067217.txt   8427592

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT supn-20180930.xml EX-101.INS 2086309
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20180930.xsd EX-101.SCH 58903
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20180930_cal.xml EX-101.CAL 77306
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20180930_def.xml EX-101.DEF 188706
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20180930_lab.xml EX-101.LAB 545705
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20180930_pre.xml EX-101.PRE 366223
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 181171666
SIC: 2834 Pharmaceutical Preparations